Antoxerene Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Antoxerene General Information

Description

Developer of drug discovery platform created to develop small molecule drugs that target protein-drug and protein-protein interactions in pathways related to aging. The company is focused on small molecule discovery through the study of protein-protein interactions and identifying and developing novel compounds to selectively destroy the toxic senescent cells and restore tissue function, thus enabling healthcare organizations to help the patients to reap the benefits of pathways of aging.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 2521 Route 20
  • La Fayette, NY 13084
  • United States
+1 (518)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2521 Route 20
  • La Fayette, NY 13084
  • United States
+1 (518)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Antoxerene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jan-2021 Completed Out of Business
1. Seed Round 25-Aug-2017 Completed Pre-Clinical Trials
To view Antoxerene’s complete valuation and funding history, request access »

Antoxerene Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Antoxerene’s complete cap table history, request access »

Antoxerene Investments (1)

Antoxerene’s most recent deal was a Joint Venture with FoxBio for . The deal was made on 12-Jul-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
FoxBio 12-Jul-2018 Joint Venture Drug Discovery
To view Antoxerene’s complete investments history, request access »

Antoxerene FAQs

  • When was Antoxerene founded?

    Antoxerene was founded in 2016.

  • Where is Antoxerene headquartered?

    Antoxerene is headquartered in La Fayette, NY.

  • What industry is Antoxerene in?

    Antoxerene’s primary industry is Drug Discovery.

  • Is Antoxerene a private or public company?

    Antoxerene is a Private company.

  • What is Antoxerene’s current revenue?

    The current revenue for Antoxerene is .

  • How much funding has Antoxerene raised over time?

    Antoxerene has raised $1.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process